Firm agreement signed to sell the Healthcare portfolio for 1.35 billion euros
Gecina’s Board of Directors has today reviewed the firm and definitive offers received in connection with the competitive sales process launched during the second half of 2015 for its healthcare real estate portfolio. After analyzing these offers, which have not been subject to any exclusive arrangements, Gecina has signed a preliminary sales agreement with Primonial Reim for its subsidiaries holding its entire healthcare real estate portfolio. On this transaction, Primonial Reim represents a club deal involving various institutional investors, including Suravenir, Aviva and a fund managed by Amundi Immobilier
The transaction represents a total of 1.35 billion euros including commissions and fees, with a net yield of 5.9% and a premium of around +16% compared with the appraisal values from June 30, 2015. This value will be used as a reference for preparing Gecina’s accounts for 2015.
The transaction will be finalized mid-2016, once the standard conditions precedent have been cleared.
This operation is perfectly aligned with the Group’s strategy to further strengthen its specialization in offices in Paris. Following this transaction, the office portfolio is expected to represent over 75% of the Group’s total portfolio.
As requested by the Board of Directors, KPMG Corporate Finance was appointed as an independent expert to review the competitive sales process.
On this transaction, Gecina has been advised by Morgan Stanley and Natixis as financial advisors, by the law firm De Pardieu Brocas Maffei for legal advice, and by the notary's office Wargny Katz.
In order to safeguard its communication, Gecina certifies its documents with Wiztrust. You can check their authenticity on the website wiztrust.com